419 related articles for article (PubMed ID: 35640416)
1. Interleukin-33 (IL-33): A critical review of its biology and the mechanisms involved in its release as a potent extracellular cytokine.
Cayrol C; Girard JP
Cytokine; 2022 Aug; 156():155891. PubMed ID: 35640416
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-33 (IL-33): A nuclear cytokine from the IL-1 family.
Cayrol C; Girard JP
Immunol Rev; 2018 Jan; 281(1):154-168. PubMed ID: 29247993
[TBL] [Abstract][Full Text] [Related]
3. Regulatory Mechanisms of IL-33-ST2-Mediated Allergic Inflammation.
Takatori H; Makita S; Ito T; Matsuki A; Nakajima H
Front Immunol; 2018; 9():2004. PubMed ID: 30233590
[TBL] [Abstract][Full Text] [Related]
4. Central domain of IL-33 is cleaved by mast cell proteases for potent activation of group-2 innate lymphoid cells.
Lefrançais E; Duval A; Mirey E; Roga S; Espinosa E; Cayrol C; Girard JP
Proc Natl Acad Sci U S A; 2014 Oct; 111(43):15502-7. PubMed ID: 25313073
[TBL] [Abstract][Full Text] [Related]
5. Respiratory syncytial virus prevents the subsequent development of ovalbumin-induced allergic responses by inhibiting ILC2 via the IL-33/ST2 pathway.
Wang D; Bai S; Cui Y; Zhao N; Qi F; Liu J; Zeng S; Xu L; Hu H; Liu B
Immunotherapy; 2018 Sep; 10(12):1065-1076. PubMed ID: 30027786
[TBL] [Abstract][Full Text] [Related]
6. IL33 and IL1RL1 variants are associated with asthma and atopy in a Brazilian population.
Queiroz GA; Costa RS; Alcantara-Neves NM; Nunes de Oliveira Costa G; Barreto ML; Carneiro VL; Figueiredo CA
Int J Immunogenet; 2017 Apr; 44(2):51-61. PubMed ID: 28266165
[TBL] [Abstract][Full Text] [Related]
7. IL33: Roles in Allergic Inflammation and Therapeutic Perspectives.
Chan BCL; Lam CWK; Tam LS; Wong CK
Front Immunol; 2019; 10():364. PubMed ID: 30886621
[TBL] [Abstract][Full Text] [Related]
8. IL-33, an Alarmin of the IL-1 Family Involved in Allergic and Non Allergic Inflammation: Focus on the Mechanisms of Regulation of Its Activity.
Cayrol C
Cells; 2021 Dec; 11(1):. PubMed ID: 35011670
[TBL] [Abstract][Full Text] [Related]
9. The interleukin-33 receptor ST2 is important for the development of peripheral airway hyperresponsiveness and inflammation in a house dust mite mouse model of asthma.
Zoltowska AM; Lei Y; Fuchs B; Rask C; Adner M; Nilsson GP
Clin Exp Allergy; 2016 Mar; 46(3):479-90. PubMed ID: 26609909
[TBL] [Abstract][Full Text] [Related]
10. Salidroside suppresses group 2 innate lymphoid cell-mediated allergic airway inflammation by targeting IL-33/ST2 axis.
Cai H; Wang J; Mo Y; Ye L; Zhu G; Song X; Zhu M; Xue X; Yang C; Jin M
Int Immunopharmacol; 2020 Apr; 81():106243. PubMed ID: 32070919
[TBL] [Abstract][Full Text] [Related]
11. The central role of IL-33/IL-1RL1 pathway in asthma: From pathogenesis to intervention.
Saikumar Jayalatha AK; Hesse L; Ketelaar ME; Koppelman GH; Nawijn MC
Pharmacol Ther; 2021 Sep; 225():107847. PubMed ID: 33819560
[TBL] [Abstract][Full Text] [Related]
12. IL-33's role in the gut immune system: A comprehensive review of its crosstalk and regulation.
Kaur H; Kaur G; Ali SA
Life Sci; 2023 Aug; 327():121868. PubMed ID: 37330043
[TBL] [Abstract][Full Text] [Related]
13. The ST2
Wachtendorf S; Jonin F; Ochel A; Heinrich F; Westendorf AM; Tiegs G; Neumann K
Front Immunol; 2024; 15():1351405. PubMed ID: 38571949
[TBL] [Abstract][Full Text] [Related]
14. ILC2 require cell-intrinsic ST2 signals to promote type 2 immune responses.
Topczewska PM; Rompe ZA; Jakob MO; Stamm A; Leclère PS; Preußer A; Duerr CU; Thole LML; Kotsch K; Artis D; Klose CSN
Front Immunol; 2023; 14():1130933. PubMed ID: 37063913
[TBL] [Abstract][Full Text] [Related]
15. Role of IL-33-ST2 pathway in regulating inflammation: current evidence and future perspectives.
Zhou Y; Xu Z; Liu Z
J Transl Med; 2023 Dec; 21(1):902. PubMed ID: 38082335
[TBL] [Abstract][Full Text] [Related]
16. Interplay Between the IL-33/ST2 Axis and Bone Marrow ILC2s in Protease Allergen-Induced IL-5-Dependent Eosinophilia.
Boberg E; Johansson K; Malmhäll C; Calvén J; Weidner J; Rådinger M
Front Immunol; 2020; 11():1058. PubMed ID: 32582171
[No Abstract] [Full Text] [Related]
17. Therapeutic Strategies for Targeting IL-33/ST2 Signalling for the Treatment of Inflammatory Diseases.
Chen WY; Tsai TH; Yang JL; Li LC
Cell Physiol Biochem; 2018; 49(1):349-358. PubMed ID: 30138941
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-33 in Tissue Homeostasis, Injury, and Inflammation.
Molofsky AB; Savage AK; Locksley RM
Immunity; 2015 Jun; 42(6):1005-19. PubMed ID: 26084021
[TBL] [Abstract][Full Text] [Related]
19. Interleukin 33 Selectively Augments Rhinovirus-Induced Type 2 Immune Responses in Asthmatic but not Healthy People.
Jurak LM; Xi Y; Landgraf M; Carroll ML; Murray L; Upham JW
Front Immunol; 2018; 9():1895. PubMed ID: 30174671
[TBL] [Abstract][Full Text] [Related]
20. Pulmonary innate lymphoid cells are major producers of IL-5 and IL-13 in murine models of allergic asthma.
Klein Wolterink RG; Kleinjan A; van Nimwegen M; Bergen I; de Bruijn M; Levani Y; Hendriks RW
Eur J Immunol; 2012 May; 42(5):1106-16. PubMed ID: 22539286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
